Latest Regulation News

BetMakers Technology Group has secured a multi-year deal with Stake.com to provide its comprehensive RaceOdds+ wagering platform, supporting Stake’s ambitious global horse racing growth plans.

Bendigo and Adelaide Bank has been hit with a $50 million operational risk capital charge by APRA, while AUSTRAC launches an enforcement investigation into serious AML/CTF breaches. The bank commits to intensifying risk management efforts amid regulatory scrutiny.

RAS Technology Holdings will not renew its Complete Racing Solution contract with Stake in 2026, shifting focus to expanding in regulated markets and Asia’s burgeoning racing sector.

Netwealth Group Limited will compensate members affected by the First Guardian Master Fund collapse with $101 million, impacting its 1H26 profit but aiming to restore member confidence swiftly.

Anson Resources has secured regulatory approval for a revised drilling approach at its Mt Fuel-Skyline Geyser Well in Utah, overcoming unexpected blockages to advance lithium exploration.

PointsBet Holdings Limited has appointed Andrew Catterall as Group CEO effective February 2026, with founder Sam Swanell transitioning to an advisory role while remaining on the Board.

Locate Technologies has completed its redomiciliation from Australia to New Zealand, establishing Locate NZ as the new parent company and appointing MUFG Pension & Market Services as its share registry provider.

The Star Entertainment Group announces the departure of CEO Steve McCann, with Executive Chairman Bruce Mathieson Jnr stepping in during the search for a new leader. This leadership change follows a strategic investment by Bally’s Corporation, signaling a new chapter for the company.

American Rare Earths has successfully produced mixed rare earth oxides from Halleck Creek ore, marking a pivotal technical breakthrough in its mineral processing program. This achievement advances the project closer to commercial viability amid growing demand for critical minerals.

Lake Resources has disclosed an inadvertent breach of ASX Listing Rule 7.1 related to the timing of share issuance under an agreement with Acuity Capital. The company is taking steps to strengthen governance and prevent future errors.

Following a critical ASIC Inquiry Interim Report, ASX has pledged a strategic reset including a $150 million capital charge and enhanced board independence to restore market confidence.

Orthocell has lodged a regulatory application to distribute its nerve repair product Remplir™ across the EU and UK, aiming to tap into a $750 million market with approval expected by Q3 2026.